Bio-Techne Corporation
TECH
$72.25
-$0.06-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.33% | -1.51% | -0.39% | -1.00% | 3.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.33% | -1.51% | -0.39% | -1.00% | 3.55% |
| Cost of Revenue | 3.14% | 0.89% | 2.41% | -4.92% | 4.72% |
| Gross Profit | 0.43% | -2.63% | -1.81% | 1.11% | 2.97% |
| SG&A Expenses | -3.59% | -28.78% | -7.68% | 3.32% | -6.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.04% | -15.79% | -3.56% | -0.35% | 2.57% |
| Operating Income | 8.03% | 98.42% | 15.09% | -4.09% | 6.42% |
| Income Before Tax | 409.20% | 86.09% | 18.44% | 19.47% | -154.87% |
| Income Tax Expenses | 409.96% | 28.64% | 59.97% | 49.23% | -582.85% |
| Earnings from Continuing Operations | 408.98% | 125.99% | 8.94% | 13.65% | -143.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 408.98% | 125.99% | 8.94% | 13.65% | -143.55% |
| EBIT | 8.03% | 98.42% | 15.09% | -4.09% | 6.42% |
| EBITDA | 3.35% | 52.91% | 6.77% | -7.46% | 3.83% |
| EPS Basic | 406.30% | 127.53% | 10.76% | 15.90% | -144.47% |
| Normalized Basic EPS | 8.60% | 90.99% | 20.43% | -1.90% | 16.65% |
| EPS Diluted | 401.03% | 128.57% | 9.09% | 14.29% | -145.25% |
| Normalized Diluted EPS | 8.56% | 91.48% | 21.16% | -0.87% | 18.07% |
| Average Basic Shares Outstanding | 0.76% | -0.66% | -1.64% | -1.93% | -1.87% |
| Average Diluted Shares Outstanding | 0.81% | -0.97% | -2.26% | -2.95% | -3.05% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.33% | -0.56% | -0.10% | -0.14% | -3.25% |